| MeSH term | MeSH ID | Detail |
|---|---|---|
| Body Weight | D001835 | 333 associated lipids |
| Arteriosclerosis | D001161 | 86 associated lipids |
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
Total
3
Norethindrone
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
Cross Reference
Introduction
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Norethindrone?
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Norethindrone
PubChem Associated disorders and diseases
What pathways are associated with Norethindrone
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Norethindrone?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Norethindrone?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Norethindrone?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Norethindrone?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Norethindrone?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Norethindrone
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| MEARS E | CLINICAL EXPERIENCE IN THE USE OF ORAL CONTRACEPTIVES. | 1964 | Proc. R. Soc. Med. | pmid:14130873 |
| KRUEGER HG and SANDERS JH | NORETHINDRONE AND MESTRANOL. EXPERIENCE IN PRIVATE PRACTICE WITH A NEW LOW-DOSAGE ORAL CONTRACEPTIVE. | 1964 | Ohio State Med J | pmid:14134747 |
| SCOVILLE AB | ORAL CONTRACEPTION. | 1964 | J Tenn Med Assoc | pmid:14135604 |
| DEHAEN P | THERAPEUTIC RESEARCH IN REVIEW. | 1964 | Med Sci | pmid:14143127 |
| FLOWERS CE | THE USE OF PROGESTINS IN OBSTETRICS AND GYNECOLOGY. | 1964 | N C Med J | pmid:14143212 |
| SATTERTHWAITE AP | A COMPARATIVE STUDY OF LOW DOSAGE ORAL CONTRACEPTIVES. | 1964 | Appl Ther | pmid:14144491 |
| FRANCIS WG | 2 MG. NORETHINDRONE-MESTRANOL IN CONTRACEPTION AND THERAPY. | 1964 | Appl Ther | pmid:14144492 |
| RINGROSE CA | PROGESTINS AND THE OVARY. | 1964 | Appl Ther | pmid:14144493 |
| MERRITT RI | THE BIOLOGICAL EFFECTS OF 2 MG. NORETHINDRONE WITH MESTRANOL. | 1964 | Appl Ther | pmid:14144494 |
| GOLDZIEHER JW | NEWER DRUGS IN ORAL CONTRACEPTION. | 1964 | Med. Clin. North Am. | pmid:14149247 |
| GERARD G et al. | [ACTION OF NORETHISTERONE ACETATE ON THE HYPOPHYSIS OF THE MALE RAT]. | 1963 | An Fac Med Univ Repub Montev Urug | pmid:14153793 |
| CHARLES D | IATROGENIC ENDOMETRIAL PATTERNS. | 1964 | J. Clin. Pathol. | pmid:14159445 |
| VOKAER R | [PROGESTERONE AND SYNTHETIC PROGESTATIVE AGENTS]. | 1964 Mar-Apr | Ann. Endocrinol. (Paris) | pmid:14163467 |
| TYLER ET | CURRENT STATUS OF LOS ANGELES ORAL CONTRACEPTION STUDIES. | 1964 | Appl Ther | pmid:14167338 |
| CAMERON WJ and WARREN JC | NORETHINDRONE MESTRANOL AS A THERAPEUTIC AGENT. | 1964 | Appl Ther | pmid:14167339 |
| LAPOINTE R | THERAPY OF CYCLIC DYSFUNCTION. | 1964 | Appl Ther | pmid:14167340 |
| CROCKER KM | MENOMETRORRHAGIA: A NEW APPROACH TO THERAPY. | 1964 | Appl Ther | pmid:14167341 |
| BURT RK | MENOPAUSAL BLEEDING. | 1964 | Appl Ther | pmid:14167342 |
| TOMPKINS MG | PROGESTINS AND THE UTERUS. | 1964 | Appl Ther | pmid:14167343 |
| SMITH GG and DICKINSON JH | THE THERAPEUTIC POTENTIAL OF NORETHINDRONE WITH MESTRANOL IN FUNCTIONAL BLEEDING. | 1964 | Appl Ther | pmid:14167344 |
| ROVINSKY JJ | CLINICAL EFFECTIVENESS OF A LOW-DOSE PROGESTIN-ESTROGEN COMBINATION. | 1964 | Obstet Gynecol | pmid:14168244 |
| NEWLAND DO et al. | EFFECTIVENESS OF A LOW-DOSE ORAL CONTRACEPTIVE TABLET. | 1964 | Obstet Gynecol | pmid:14168258 |
| PALVA IP and MUSTALA OO | ORAL CONTRACEPTIVES AND LIVER DAMAGE. | 1964 | Br Med J | pmid:14171108 |
| SHEARMAN RP | OVARIAN FUNCTION DURING AND AFTER LONG-TERM TREATMENT WITH OVULATION INHIBITORS. | 1964 | Lancet | pmid:14172349 |
| ANCLA M and BELAISCH J | [ACTION OF NORESTHISTERONE ON CERTAIN INTRANUCLEAR CORPUSCLES PRESENT IN THE GLANDULAR EPITHELIUM OF HUMAN ENDOMETRIUM. STUDY BY ELECTRON MICROSCOPE]. | 1964 | Rev Fr Etud Clin Biol | pmid:14172581 |
| MAMOU H et al. | [RECURRENT PAROTITIS TREATED BY 19-NORSTEROIDS]. | 1964 | Sem Hop | pmid:14174424 |
| HENZL M et al. | [PROLIFERATIVE EFFECT OF 17-ALPHA-ETHINYL-19-NORTESTOSTERONE]. | 1964 | Arch Gynakol | pmid:14174811 |
| MATTHEWS JG | ORTHO-NOVUM 2 MG. IN CONCEPTION CONTROL. | 1964 | J Am Osteopath Assoc | pmid:14181590 |
| TYLER ET | EIGHT YEARS' EXPERIENCE WITH ORAL CONTRACEPTION AND AN ANALYSIS OF USE OF LOW-DOSAGE NORETHISTERONE. | 1964 | Br Med J | pmid:14191889 |
| DUNCAN GW et al. | EFFECT OF 7-ALPHA-METHYLATION ON BIOLOGICAL ACTIVITIES ON NORETHINDRONE. | 1964 | Proc. Soc. Exp. Biol. Med. | pmid:14197511 |
| ZILKHA KJ | CEREBROVASCULAR ACCIDENTS AND ORAL CONTRACEPTION. | 1964 | Br Med J | pmid:14198735 |
| WHARTON LR and SCOTT RB | EXPERIMENTAL PRODUCTION OF GENITAL LESIONS WITH NORETHINDRONE. | 1964 | Am. J. Obstet. Gynecol. | pmid:14198966 |
| BEER MA | CONTRACEPTIVE EFFICACY OF NORETHINDRONE WITH MESTRANOL: NEW LOW DOSAGE FORM. | 1964 | J Med Soc N J | pmid:14199356 |
| TREICHLER HP and HORVATH PN | ERYTHEMA MULTIFORME EXUDATIVUM (STEVENS-JOHNSON SYNDROME) IN EARLY PREGNANCY: REPORT OF A CASE. | 1964 | Obstet Gynecol | pmid:14199548 |
| MATTHEWS JG | CONTROLLED RHYTHM: A PRELIMINARY REPORT. | 1964 | J Am Osteopath Assoc | pmid:14199890 |
| PETERSON DL et al. | STEROID-INDUCED BLOCK OF OVARIAN COMPENSATORY HYPERTROPHY IN HEMICASTRATED FEMALE RATS. | 1964 | J. Endocrinol. | pmid:14200359 |
| TAYMOR ML | EFFECT OF SYNTHETIC PROGESTINS ON PITUITARY GONADOTROPHIN EXCRETION. | 1964 | J. Clin. Endocrinol. Metab. | pmid:14202759 |
| DAUWE O | [ARTIFICIAL ARREST OF OVULATION]. | 1964 | Scalpel (Brux) | pmid:14203004 |
| BEHRMAN SJ | NORETHINDRONE, 2 MG.: AN EVALUATION. | 1964 | Obstet Gynecol | pmid:14211016 |
| PRAKASH S and SCULLY RE | SARCOMA-LIKE PSEUDOPREGNANCY. CHANGES IN UTERINE LEIOMYOMAS. REPORT OF A CASE RESULTING FROM PROLONGED NORETHINDRONE THERAPY. | 1964 | Obstet Gynecol | pmid:14211017 |
| WATTS GF et al. | PREGNANCY FOLLOWING WITHDRAWAL FROM ORAL CONTRACEPTIVE MEASURES. | 1964 | Am. J. Obstet. Gynecol. | pmid:14212800 |
| HARTVEIT F | COMPLICATIONS OF ORAL CONTRACEPTION. | 1965 | Br Med J | pmid:14213119 |
| FLORSHEIM WH and FAIRCLOTH MA | EFFECTS OF ORAL OVULATION INHIBITORS ON SERUM PROTEIN-BOUND IODINE AND THYROXINE BINDING PROTEINS. | 1964 | Proc. Soc. Exp. Biol. Med. | pmid:14219959 |
| DESAULLES PA and KRAEHENBUEHL C | COMPARISON OF THE ANTI-FERTILITY AND SEX HORMONAL ACTIVITIES OF SEX HORMONES AND THEIR DERIVATIVES. | 1964 | Acta Endocrinol. | pmid:14225842 |
| BOARD JA and BORLAND DS | ENDOMETRIAL EFFECTS OF MESTRANOL-NORETHINDRONE SEQUENTIAL THERAPY FOR ORAL CONTRACEPTION. | 1964 | Obstet Gynecol | pmid:14227594 |
| FRANCIS WG and DALZEIL D | ACCIDENTAL INGESTION OF ORAL CONTRACEPTIVES BY CHILDREN. | 1965 | Can Med Assoc J | pmid:14232198 |
| Jeng MH et al. | Estrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferation. | 1992 | Cancer Res. | pmid:1423300 |
| GOODRICH SM and WOOD JE | PERIPHERAL VENOUS DISTENSIBILITY AND VELOCITY OF VENOUS BLOOD FLOW DURING PREGNANCY OR DURING ORAL CONTRACEPTIVE THERAPY. | 1964 | Am. J. Obstet. Gynecol. | pmid:14233661 |
| BAINES GF | JAUNDICE IN A PATIENT TAKING NORETHISTERONE COMPOUND TABLETS. | 1965 | Lancet | pmid:14234193 |
| SHELLEY WB and RESNIK SS | METHYSERGIDE INDUCED DEGRANULATION OF THE BASOPHIL LEUKOCYTE IN MAN. | 1964 | J. Invest. Dermatol. | pmid:14234855 |